Statera Biopharma, Inc. Operating Lease, Payments
Statera Biopharma, Inc. reported Operating Lease, Payments of $162.94 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-10-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-10-06
- Statera Biopharma, Inc. operating lease, payments for the quarter ending 2021-12-31 was $80.45K.
- Statera Biopharma, Inc. operating lease, payments for the quarter ending 2020-12-31 was $0.00.
- Statera Biopharma, Inc. operating lease, payments for fiscal 2021 was $162.94K, a 4904.18% increase from fiscal 2020.
- Statera Biopharma, Inc. operating lease, payments for fiscal 2020 was $3.26K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|
| 2021-12-31 | $80.45K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $162.94K 10-K · filed 2022-10-06 | |
| 2021-09-30 | $82.49K 10-Q · filed 2021-11-15 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $3.26K 10-K · filed 2022-10-06 | |
| 2020-09-30 | $3.26K 10-Q · filed 2021-11-15 |